Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Oxytocin
, a protein hormone mainly produced by hypothalamus, has been shown to repress body weight gain in obese animals, in part, by reducing food intake and increasing energy expenditure. Till now, activation of brown fat tissue (BAT) thermogenesis and white adipose tissue (WAT) browning are considered as two main factors for
oxytocin
-induced energy expenditure. However, the underlying molecular mechanisms are still not understood well. Here, we observed that
oxytocin
expression in the hypothalamus and its receptor in adipose tissues were induced by cold exposure in mice. In differentiated adipocytes,
oxytocin
stimulated brown adipocyte specific gene expression by inducing
PRDM16
. In high fat diet induced obese mice,
oxytocin
delivery by osmotic minipumps increased body core temperature and decreased body weight gain. Glucose and insulin tolerance were improved by
oxytocin
. Hyperinsulinemia and fatty liver were ameliorated in
oxytocin
-treated animals. Moreover,
oxytocin
treatment induced thermogenic gene expressions in BAT, inguinal WAT (iWAT), and skeletal muscle. Taken together, our findings revealed a new aspect of
oxytocin
, i.e.
oxytocin
induces iWAT browning and stimulates thermogenesis in BAT, iWAT and skeletal muscle, through which
oxytocin
promotes thermogenesis and thus combats obesity and metabolic dysfunctions.
...
PMID:The effects of oxytocin to rectify metabolic dysfunction in obese mice are associated with increased thermogenesis. 3253 19